Eli A. Friedman, M.D.

Within the past three years, Dr. Friedman has received grant/research support from Alteon.

Release Date: 07/30/2002
Termination Date: 07/30/2005

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

• Discuss how renal failure in a person with diabetes may result from causes other than diabetic nephropathy
• Discuss the occurrence of causes of renal disease other than diabetic nephropathy in diabetic persons and enumerate the varied therapeutic options open to the uremic diabetic patient
• Describe early perturbations in diabetic nephropathy
• Discuss the significance of renal functional changes in early (incipient) diabetic nephropathy
• Evaluate the comparative risk/benefit of pancreas transplants as a therapeutic option for uremic individuals with type 1 diabetes.

 

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity